Philip Dormitzer, Novartis to Speak at Vaccines Meeting, July 9, 2014, in Boston

Monrovia, CA, May 11, 2014 --(PR.com)-- Philip R. Dormitzer, Head of US Research, Global Head of Virology, Vice President at Novartis Vaccines and Diagnostics to Present at the 12th Vaccines Research & Development: All Things Considered Conference on July 9-11, 2014, in Boston, MA, by GTCBio.

GTCBio’s annual Vaccines Conference continues a tradition of presenting valuable updates and exposure to all aspects of vaccine development in a comfortable, interactive and friendly setting with leaders in vaccinology from industry, academia, and the government examining vaccine development from basic research to marketing. We bring together the people who make the discoveries, make the decisions, fund the work and license the vaccines and foster their interaction with the attendees to share their perspectives of the vaccine industry.

The program features presentations from S. Mark Tompkins, University of Georgia; Katarina Radosevic, Crucell Vaccine Institute, Janssen Center of Excellence for Immunoprophylaxis; Michael W. Deem, Rice University; Chih-Jen (CJ) Wei, Sanofi Pasteur; Joseph G. Joyce, Merck Research Laboratories; Daniel Wattendorf, Defense Advanced Research Projects Agency (DARPA); Richard Malley, Children's Hospital Boston; Dan Barouch, Harvard Medical School; Thomas Kosten, Baylor College of Medicine; Jay Evans, GSK Vaccines and many more!

This conference is also part of the Infectious Diseases World Summit 2014, which consists of this and two other conferences:
1) 3rd Annual Influenza Research and Development Conference
2) 11th Anti-Infectives Partnering and Deal-Making Conference

For more information, please visit www.gtcbio.com